Attention Deficit Hyperactivity Disorder (ADHD)

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/74

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

75 Terms

1
New cards

ADHD is the most common

neurodevelopmental disorder in children w/ higher prevalence in males compared to females

2
New cards

ADHD is a chronic illness that can

continue to cause sx throughout adolescence & adulthood

3
New cards

ADHD is characterized by sx of

inattention

hyperactivity

impulsivity

difficulty focusing

easily distracted

trouble staying still

frequently unable to control impulsive behavior

4
New cards

pathogenesis of ADHD

imbalance of catecholamine metabolism, w/ subsequent decreased dopaminergic activity, is thought to play a role

5
New cards

stimulant medications are primary tx for ADHD because

they raise dopamine and NE levels by blocking the reuptake of NE and dopamine

-doses usually titrated up every 7 days as needed to reduce AE

-do not need to be tapered off

6
New cards

tx of ADHD includes

combination of medication and behavioral therapy

7
New cards

1st line tx for preschool-aged children (age 4-5 years) is

parent training in behavior management and/or behavioral classroom intervention

8
New cards

2nd line tx for preschool aged children (aged 4-5 years)

methylphenidate

9
New cards

1st line tx in pt >/ 6yo

ADHD medications + behavioral interventions

10
New cards

diagnostic criteria used for ADHD

Diagnostic and Statistical Manual of Mental Disorders (DSM-5)

-based on primary sx, inattention and/or hyperactivity and impulsivity

11
New cards

inattention is defined as

-loses things

-easily distracted

-forgetful

>/ 6 sx of inattention for children / 5 sx for ages >/ 17 yo

sx must be present for AT LEAST 6 months and are inappropriate for the developmental level

12
New cards

hyperactivity & impulsivity

-blurts out answers

-trouble waiting his/her turn

-interrupts or intrudes on others

>/ 6 sx of hyperactivity-impulsivity for children / 5 sx for ages >/ 17 yo

sx must be present for AT LEAST 6 months and are inappropriate for the developmental level

13
New cards

conditions for ADHD that must be met

-several inattentive or hyperactive-impulsive sx present before 12yo

-sx must have been present in 2 or more settings (home, school. work, w/ friends, etc)

-sx interfere w/ functioning and are not caused by another disorder

14
New cards

natural products for ADHD

fish oil -- not routinely recommended

melatonin --used for sleep onset insomnia when taking stimulants

15
New cards

1st line medications for ADHD

stimulants

16
New cards

preferred for children

long acting formulations

-avoid need for a dose during school

-steady sx control

17
New cards

if stimulants do not work well enough (after 2 - 3 medication trials) or the AE are intolerable

a nonstimulant medication can be tried

-atomoxetine

-guanfacine ER

18
New cards

non stimulants are used 1st line when

prescribers worried about stimulant abuse or diversion by pt or family

19
New cards

Almost all ADHD medications are approved for use in

adults and children >/ 6 yo

20
New cards

capsules that can be opened and contents sprinkled on a small amount of ______

-Adderall XR

-Ritalin LA

-Vyanse

21
New cards

Vyvanse capsule contents can be mixed in

water, orange juice or yogurt

22
New cards

Adderall XR or Ritalin LA can be opened and sprinkled on

small amount of applesauce

23
New cards

pt friendly formulations for stimulants

-capsules that can be opened

-chewable tablets (Vyvanse)

-patches (Daytrana)

-suspensions

24
New cards

add on medications for ADHD tx is

-guanfacine ER (intuniv)

-clonidine ER (Kapvay)

25
New cards

medicine to help sleep at night

clonidine IR

diphenhydramine

Melatonin

26
New cards

what stimulant is taken in the evening

Jornay PM

27
New cards

all stimulants are

Control 2 and must be dispensed with a MedGuide

28
New cards

BBW for Stimulants

abuse

misuse (can lead to OD and death)

addiction

29
New cards

CI for Stimulants

do not use within 14 days of MAO inhibitor due to risk of hypertensive crisis when used together

30
New cards

Warnings for Stimulants

-drug diversion for non-medical, illicit use and/or distribution

-incr. level of dopamine and NE can incr. HR & BP & cause serious CV events in children and adults w/ or w/o preexisting cardiac disease

-priapism (prolonged painful erection >/ 4 hrs)

-Raynaud's disease (cold body parts)

-new onset psychosis or mania, or an exacerbation of preexisting psychosis (mixed/manic episodes in bipolar)

-loss of appetite (can decr. child's growth trajectory)

-risk of serotonin syndrome is incr. w/ other serotonergic drugs

-lower seizure threshold which incr risk for seizures

-visual disturbance can occur

31
New cards

methylphenidate brands

Ritalin

Methylin

Concerta

Relexii

Ritalin LA

Aptensio XR

Jornay PM

Quillivant XR

QuilliChew ER

Cotempla XR-ODT

Daytrana

32
New cards

methylphenidate transdermal patch

Daytrana (10mg/9hr patch QAM)

-loss of skin pigmentation at site (resemble vitiligo)

-apply to the hip 2 hours before desired effect

-remove after 9 hours

-alternate hips daily

-discard by flushing down toilet

33
New cards

methylphenidate ER orally disintegrating tablet (ODT)

Cotempla XR-ODT

34
New cards

methylphenidate ER chewable tablet

QuilliChew ER

-contains phenylalanine

-avoid w/ PKU

35
New cards

methylphenidate oral suspension

Quillivant XR

36
New cards

Jornay PM

methylphenidate ER capsule

-20mg QPM (evening)

-outer coating delays initial drug release 10 hours to allow for evening dosing

-inner coating controls the slow release of the drug during the day

37
New cards

methylphenidate ER capsule

Ritalin LA

Aptensio XR

Jornay PM

38
New cards

methylphenidate ER tablet w/ osmotic release oral system (OROS) delivery

Concerta

Relexxi

-18 to 36mg QAM

max 72mg/day

-ghost tablet in stool

-harder to crush (decr. abuse potential)

-do not use either with GI narrowing conditions (motility issues, small bowel disease)

-outer coat dissolves fast to provide Immediate action & rest is released slowly

39
New cards

methylphenidate IR oral solution

Methylin

40
New cards

methylphenidate IR tablet

Ritalin

-5mg BID 30 min before breakfast & lunch

-max 60mg/day

41
New cards

AE of methylphenidate

insomnia

decr appetite/weight loss

headache

irritability

nausea/vomiting

blurry vision

dry mouth

42
New cards

dexmethylphenidate brands

Focalin (BID)

Focalin XR

43
New cards

dexmethylphenidate comes as

IR tablet & ER capsule

-isomer of methylphenidate

-convert from methylphenidate to dexmethylphenidate use 1/2 of TDD of methylphenidate

therefore methylphenidate TDD is 10mg then dexmethylphendiate TDD is 5mg

44
New cards

serdexmethylphenidate/dexmethylphenidate

Azstarys capsule

-prodrug of dexmethylphenidate

-provides extended duration of action following faster acting dexmethylphenidate

45
New cards

dextroamphetamine/amphetamine IR tablet

Adderall

-due to IR tablet w/ dextroamphetamine approved for kids / 3 yo

46
New cards

dextroamphetamine/amphetamine ER capsule

Adderal XR

Mydayis

-due to dextroamphetamine not recommended in kids

47
New cards

amphetamine brands

Adzenys XR-ODT

Dyanavel XR (chewable tablet/oral suspension)

Evekeo

Evekeo ODT

48
New cards

All amphetamine & dextroamphetamine IR products

approved for children >/ 3 yo

EXCEPT

Evekeo ODT

49
New cards

All amphetamine & dextroamphetamine products should not be taken w/

acidic foods such as juice or vitamin C due to decr absorption

50
New cards

All amphetamine & dextroamphetamine ER products

-cannot be substituted for other amphetamine products on mg-per-mg basis

51
New cards

amphetamine ER orally-disintegrating tablet

Adzenys XR-ODT

-cannot be substituted for other amphetamine products on mg-per-mg basis

52
New cards

amphetamine ER tablet (can be chewed)

Dyanavel XR

-cannot be substituted for other amphetamine products on mg-per-mg basis

53
New cards

amphetamine ER oral suspension

Dyanavel XR

-shake suspension prior to use

-cannot be substituted for other amphetamine products on mg-per-mg basis

54
New cards

amphetamine IR tablet

Evekeo

55
New cards

amphetamine IR orally-disintegrating tablet

Evekeo ODT

-not approved for children

56
New cards

dextroamphetamine age group

not recommended in children

57
New cards

Dextroamphetamine brands

Dexedrine

ProCentra

Zenzedi

Xelstrym

58
New cards

dextroamphetamine ER capsule

Dexedrine

59
New cards

dextroamphetamine IR oral solution

ProCentra

60
New cards

dextroamphetamine IR tablet

Zenzedi

61
New cards

dextroamphetamine ER patch

Xelstrym

62
New cards

lisdexamfetamine is

prodrug of dextroamphetamine

63
New cards

lisdexamfetamine brand

Vyvanse

capsule and chewable tablet formulations

-children 20-30mg QAM

-adults 30mg QAM

max 70mg/day

-low abuse potential

-prodrug composed of l-lysine (amino acid) bonded to dextroamphetamine

-hydrolyzed in the blood to active dextroamphetamine

-if injected or snorted the fast effect/rush is MUTED

64
New cards

methamphetamine brand

Desoxyn

tablet

QAM or BID

65
New cards

non stimulants are used

2nd line if trials of stimulant medications fail or side effects are intolerable

-used 1st line if prescriber has concerns of abuse or diversion potential

66
New cards

Selective NE Reuptake Inhibitor Non-stimulants (only as capsules)

Atomoxetine (Strattera)

Viloxazine (Qelbree)

-risk of suicidal ideation

-CI: MAOi in past 14 days

-risks: CV events, psychos/mania

-AE: decr. appetite, insomnia, somnolence, dry mouth, incr BP, incr HR, headache, nausea, abdominal pain

67
New cards

Centrally Acting Alpha 2 Adrenergic Receptor Agonists Non-Stimulant (only as tablets)

Clondine ER (Kapvay)

Clonidine IR

Clonidine ER (Nexiclon XR)

Clonidine patch --for HTN only

Guanfacine ER (Intuniv)

Guanfacine IR -- for HTN only

68
New cards

centrally acting alpha 2 adrenergic receptor agonists non-stimulants warnings, AE, & notes

-do not d/c abruptly (can cause rebound HTN)

-dose/dep CV effects (brady/hypotension/orthostasis/syncope)

-sedation/drowsiness

-additive sedation can occur when used in combo w/ other CNS depressants

-use caution w/ other drugs that decr. BP and HR (BB/nonDHP)

-AE: dry mouth, somnolence, fatigue, dizziness, constipation, decr. HR, hypotension, headache, nausea, abdominal pain

-do not substitute IR formulations for ER formulations

-must be tapered off to decr risk of rebound HTN

taper by: decr dose by

69
New cards

Atomoxetine

Strattera (CYP2D6 substrate)

max 100mg/day

-if take w/ strong CYP2D6 inhibitor (paroxetine) max dose is 80mg/day

-2d6 inhibitors OR inducers can change dose of atomoxetine

-can take in divided doses if needed

-do not open capsule (ocular irritant)

-CI: glaucoma, pheochromocytoma, severe CV disorders

-Warnings: aggressive behavior, hepatotoxicity, priapism, urinary hesitancy and retention, growth delays

-SNRI but MedGuide required

70
New cards

Viloxazine

Qelbree (strong 1A2 inhibitor & weak 2D6 & 3A4 inhibitor)

-max 400mg/day in children < 18yo

-max 600mg/day in adults

-if severe renal impaired reduce dose

-CI: concurrent use of major CYP1A2 substrates (or substrates w/ NTI)

-capsule can be opened and contents sprinkled on 1 teaspoon of pudding or applesauce, which must be swallowed withOUT chewing

-SNRI but MedGuide required

71
New cards

Clonidine ER

Kapvay or Nexiclon XR

-0.1mg QHS incr by 0.1mg weekly and if take BID w/ higher dose at night

-max 0.4mg/day

-decr by

72
New cards

clonidine patch

is used only for HTN

73
New cards

Guanfacine ER

Intuniv

-1mg daily and incr. by

74
New cards

Guanfacine IR

for HTN only

75
New cards

stimulant chewable tablets

vyvanse

QuilliChew ER (avoid in PKU)--methylphenidate ER tablet

methylphenidate IR tablet (no brand name)